Authors:
Albers, GW
Bogousslavsky, J
Bozik, MA
Brass, LM
Broderick, JP
Fisher, M
Goldstein, LB
Salazar-Grueso, E
Akitsuki, S
Aranko, K
Ashwood, T
Atkinson, RP
Bell, RD
Brott, TG
Cady, WJ
Caplan, LR
Coggins, S
Cramer, S
Cyrus, P
Dayno, J
Easton, JD
Elliott, PJ
Finklestein, SP
Furlan, AJ
Gamzu, E
Glasky, MS
Gordon, K
Gorelick, PB
Greenwood, DT
Grotta, JC
Gunn, K
Hachinski, V
Hacke, W
Hall, ED
Hsu, CY
Humphreys, DM
Ishikawa, H
Jacobs, AJ
Kaste, M
Koroshetz, WJ
Krams, M
Lauritano, AA
Leclerc, J
Lees, KR
Lesko, L
Levine, SR
Levy, DE
Li, FH
Lyden, PD
Masayasu, H
McDermott, J
Meibach, RC
Meya, U
Miyairi, K
Niidome, T
Oeda, J
Poole, RM
Ron, ES
Sacco, RL
Saltarelli, MD
Shimizu, K
Shook, BJ
Soehngen, M
Soehngen, W
Stamler, DA
Styren, SD
Teal, PA
Tilley, BC
Traystman, RJ
Walker, MD
Wallin, BA
Warach, S
Ward, DP
Wessel, TC
Wettstein, J
Citation: Gw. Albers et al., Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II), STROKE, 32(7), 2001, pp. 1598-1606